Results 221 to 230 of about 2,922,217 (272)

Nivolumab plus brentuximab vedotin for relapsed/refractory diffuse large B-cell lymphoma. [PDF]

open access: yesFuture Oncol
Johnson NA   +19 more
europepmc   +1 more source

Mapping CSC‐Mediated Ovarian Cancer Chemoresistance via CXCR4‐PET to Guide Precision Cisplatin Re‐Sensitization Therapy

open access: yesAdvanced Science, EarlyView.
CXCR4 functions as a potential cancer stem cell‐associated marker linked to chemoresistance in ovarian cancer, and an inhibitor of CXCR4, AMD3100, can enhance the cytotoxic response to cisplatin. Based on these findings, [68Ga]Ga‐Pentixafor positron emission tomography enables selective visualization of CXCR4‐high ovarian cancer, while AMD3100 combined
Lixia Feng   +12 more
wiley   +1 more source

Immediate one-stage subcutaneous breast reconstruction without ADM: A single-center 6-year experience. [PDF]

open access: yesJPRAS Open
Russo A   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy